Results 221 to 230 of about 20,344 (273)

Blocking Sphingosine 1-phosphate Metabolism With Fingolimod Prevents the Progression of Vascular Smooth Muscle Cells Calcification in Chronic Kidney Disease. [PDF]

open access: yesJ Cell Physiol
Skafi N   +16 more
europepmc   +1 more source

Osteocytic vinculin controls bone mass by modulating Mef2c-driven sclerostin expression in mice. [PDF]

open access: yesBone Res
Wang Y   +9 more
europepmc   +1 more source

Novel Aptamers Targeting Sclerostin Loop3 Improve Skeletal and Muscle Properties Without Adverse Cardiovascular Effects in Orchiectomized Mice. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Zhou B   +12 more
europepmc   +1 more source

Evaluating Sclerostin as a Biomarker for Bone Health in Hyperthyroidism: A Clinical and Hormonal Correlation Study.

open access: yesJ Pharm Bioallied Sci
Thambidurai I   +5 more
europepmc   +1 more source

Sclerostin

Current Opinion in Endocrinology, Diabetes & Obesity, 2014
Discovery of the Wnt signaling pathway and understanding the central role of osteocyte in skeletal homeostasis have been the major advances in skeletal biology over the past decade. Sclerostin, secreted mainly (but not exclusively) by osteocytes, has emerged as a key player in skeletal homeostasis.
Mahalakshmi, Honasoge   +2 more
openaire   +2 more sources

Sclerostin deficiency in humans

Bone, 2017
Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological, and histological characteristics of patients with sclerosteosis and van Buchem disease that led to a better understanding of the role of ...
Lierop, A.H. van   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy